Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
5.02
-0.47 (-8.56%)
Dec 20, 2024, 4:00 PM EST - Market closed
Traws Pharma Employees
As of December 31, 2023, Traws Pharma had 18 total employees, including 17 full-time and 1 part-time employees. The number of employees increased by 1 or 5.88% compared to the previous year.
Employees
18
Change (1Y)
1
Growth (1Y)
5.88%
Revenue / Employee
$12,556
Profits / Employee
-$7,821,389
Market Cap
15.19M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ImmunoPrecise Antibodies | 101 |
bioAffinity Technologies | 75 |
BioXcel Therapeutics | 74 |
Nephros | 31 |
Palatin Technologies | 30 |
Spruce Biosciences | 29 |
Microbot Medical | 22 |
Minerva Neurosciences | 9 |
TRAW News
- 5 weeks ago - Traws Pharma Provides Business Update and Reports Q3 2024 Financial Results - GlobeNewsWire
- 2 months ago - Traws Pharma Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir Marboxil - GlobeNewsWire
- 2 months ago - Traws Pharma Announces Positive Topline Phase 1 Results for COVID Candidate, Ratutrelvir, an Oral Mpro Inhibitor - GlobeNewsWire
- 3 months ago - Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors - GlobeNewsWire
- 3 months ago - Traws Pharma, Inc. Announces Special Shareholders Meeting Results - GlobeNewsWire
- 4 months ago - Traws Pharma, Inc. (TRAW) Corporate Update Call Transcript - Seeking Alpha
- 4 months ago - Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business Highlights - GlobeNewsWire
- 4 months ago - Traws Pharma to Host Corporate Update Call on August 15, 2024, at 8:00 AM ET - GlobeNewsWire